CAPR News & Analysis
1 article
Market Mood
0 Bullish1 Neutral0 Bearish
Capricor Therapeutics (CAPR) Files Form 144 on May 19
Capricor Therapeutics (CAPR) submitted Form 144 on May 19, indicating the intention to sell shares for a specified amount. This filing is a regulatory requirement for sellers of restricted securities. The document helps investors understand potential selling pressure on the stock. Such transactions may impact trading volumes and share price.
Read More